Pharmafile Logo
Pharmafocus logo
Advanced Search

HIV

Showing 15 posts of 200 posts found.

Isentress image

Merck puts HIV drug in shared patent pool

February 24, 2015
Research and Development, Sales and Marketing AbbVie, Gilead, HIV, Merck, Raltegravir, Roche, isentress

Merck is teaming up with the Medicines Patent Pool (MPP) to license its paediatric HIV treatment in developing countries. The …

News
Pharma image

Pharma’s reputation ‘is worsening among patients’

February 10, 2015
Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency

Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …

News
GSK image

GSK blames respiratory woes as sales drop

February 5, 2015
Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales

GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …

News

Gilead and Strides partner in HIV

January 21, 2015
Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf

Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …

News
Viekirax and Exviera image

AbbVie Hep C combo pill ready for Europe

January 16, 2015
Medical Communications AbbVie, Exviera, FDA, HIV, Viekira Pak, Viekirax, harvoni, hep C, sovaldi

The European Commission has approved AbbVie’s Viekirax and Exviera for the treatment of chronic hepatitis C (HCV). Viekirax (ombitasvir/paritaprevir/ritonavir) and …

News
Pfizer image

New Lyrica formulation effective in trials

December 19, 2014
Sales and Marketing HIV, Lyrica, Pfizer, pain, pregabalin, shingles

Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …

News
Janssen image

Janssen launches HIV combination pill

December 17, 2014
Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …

News
Viiv image

GSK mulls $27 billion ViiV sell-off

October 23, 2014
Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV

After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …

News

More action needed on antibiotic resistance

July 25, 2014
Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh

Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

News
Sovaldi (sofosbuvir) image

Sovaldi scores in HIV patients

July 21, 2014
Sales and Marketing Gilead, HIV, JAMA, hep C, hepatitis C, sovaldi

Patients with HIV and hepatitis C virus (HCV) have responded well to a combination of Gilead Sciences’ Sovaldi and ribavirin …

News
Map image

Twitter useful for tracking HIV outbreaks

March 5, 2014
Medical Communications, Sales and Marketing AIDS, HIV, Twitter, digital, flu, ucla, virus, wells

A study by UCLA researchers has shown that Twitter and social media can be used as a practical real-time tool …

News
Abbvie image

AbbVie ‘pleased’ with first year

February 3, 2014
Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira

Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …

News
BMS image

BMS abandons hep C, diabetes and neuroscience

November 11, 2013
Sales and Marketing BMS, HIV, diabetes, hep C

Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …

News
Roche image

Roche allows Valcyte access

August 5, 2013
Sales and Marketing HIV, Roche, valcyte

Roche has signed a deal with a United Nations initiative to open up access to an oral drug which is …

News
Stribild image

New HIV pill for UK

May 29, 2013
Sales and Marketing Gilead, HIV, stribild

Gilead Sciences has launched Stribild, a once-daily single tablet regimen to combat HIV – the virus which causes AIDS – …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025